The ability to print defined patterns of cells and extracellular-matrix components in three dimensions has enabled the engineering of simple biological tissues, however bioprinting functional solid organs is beyond the capabilities of current biofabrication technologies. An alternative approach would be to bioprint the developmental precursor to an adult organ, using this engineered rudiment as a template for subsequent organogenesis in vivo. Here we demonstrate that developmentally inspired hypertrophic cartilage templates can be engineered in vitro using stem cells within a supporting gamma-irradiated alginate bioink incorporating Arg-Gly-Asp (RGD) adhesion peptides.
Introduction
Bioprinting is an emerging tool to spatially control the deposition of biomaterials, biomolecules and/or cells in predefined three dimensional (3D) patterns [1] [2] [3] . This technology has already been used to engineer constructs that mimic aspects of the anatomical and structural complexity of relatively thin tissues and hollow tubes such as skin [4] , blood vessels [5] and articular cartilage [6] . However reproducing the complex cellular and extra-cellular micro-organisation of an entire solid organ is well beyond the capabilities of currently available bioprinting technologies. An alternative approach would be to bioprint the developmental precursor of a more complex organ, as the structure and composition of such rudiments are typically less complex than their adult counterparts. If such developmentally inspired bioprinted implants can be provided with adequate mechanical support to survive and function within the adult body, they may provide a template to instruct organogenesis in vivo. Such a developmental engineering approach would add a new dimension to the traditional bioprinting paradigm by providing organ pre-cursors with the capacity to mature into their more complex adult counterparts over time in vivo.
During skeletogenesis the long bones of the body are formed by endochondral ossification, whereby chondrocytes within the developing limb bud undergo a coordinated sequence of proliferation and hypertrophy, providing a growing template for bone formation [7, 8] . Cartilage canals within this cartilaginous precursor act as conduits for vascular invasion to enable its conversion into bone [9] . It has been demonstrated that cartilaginous templates generated in vitro using adult mesenchymal stem cells (MSCs) are vascularised and form bone following implantation [10] [11] [12] [13] , suggesting that such engineered tissues could be used for the reconstruction of large bone defects. A central challenge with the translation of such developmentally inspired engineering strategies is ensuring that these immature soft tissues, which are designed to function in the relatively low load bearing environment of the developing limb, are provided with the necessary mechanical support to execute their function in the adult body.
reinforced, hypertrophic cartilage templates which develop over time in vivo to give rise to whole bone organs. A range of hydrogel bioinks were first compared for their capacity to support chondrogenesis of MSCs in vitro and endochondral bone formation in vivo. An array of microchannels inspired by the cartilage canal network that form during long bone development were introduced into the bioprinted constructs to support their vascularisation and conversion into endochondral bone [14] . These engineered hypertrophic cartilaginous templates were then mechanically reinforced with a network of printed polycaprolactone (PCL) microfibers. Finally, we demonstrate the power of this developmental 3D bioprinting approach by using multi-tool biofabrication to engineer developmentally inspired templates mimicking the geometry and bulk mechanical properties of a vertebral body, which over time in vivo matured into a vascularized bone organ.
Results

Printable Hydrogels for Endochondral Bone Tissue Engineering
Realising the objectives of this study first required the identification of a hydrogel bioink that was both compatible with 3D bioprinting and also capable of supporting robust chondrogenesis in vitro and endochondral bone formation in vivo. Three hydrogels compatible with 3D bioprinting, namely a gamma-irradiated alginate incorporating Arg-Gly-Asp (RGD) specific adhesion peptides (RGD-γ alginate; previously developed to support bone regeneration [15] [16] [17] ), a commercially available poly (ethylene glycol) methacrylate (PEGMA) based hydrogel designed specifically for 3D
Bioprinting (marketed as BioINK TM ) and finally Gelatin methacrylamide (GelMA) [18] , were first compared for their capacity to support chondrogenesis of bone marrow derived MSCs (Figure 1a ).
MSCs were encapsulated in each of the hydrogels and cultured in chondrogenic conditions for a period of 4 weeks. To compare the printability of each hydrogel cell laden filaments were deposited onto a glass slide using a 25G needle (260μm) and the average filament diameter was measured
(Figure S1 c).
Histological and immunohistochemical staining at the end of the 4 week in vitro culture period demonstrated that each hydrogel supported differing degrees of chondrogenesis ( Figure. 1b) . RGD-γ alginate supported stronger chondrogenic differentiation, with engineered tissues staining intensely for sGAG and collagen type II (Figure 1b i, vii) . In contrast, the GelMA and PEGMA hydrogels supported lower levels of sGAG and collagen type II staining (Figure 1b ii, iii, viii, ix). sGAG synthesis (sGAG/DNA) was significantly lower in the GelMA constructs compared to all other hydrogels (Figure 1b xviii, xix) . Cells encapsulated in RGD-γ alginate hydrogels appeared larger in volume with more well developed lacunae (Figure 1b iv) . Negligible collagen type X, a marker of chondrocyte hypertrophy, was found in PEGMA and GelMA, with slightly higher staining noted in peri-cellular regions of the RGD-γ alginate hydrogel (Figure 1b iv-vi) . Acellular staining for sGAG and day 0 sGAG/DNA values for each biopolymer are also provided in (Figure S1 a-c) .
Next the chondrogenically primed hydrogels were implanted subcutaneously into nude mice to compare their capacity to support the conversion of an engineered cartilage template into bone in vivo. H&E staining, as well as µCT analysis, were used to assess spatial bone formation. Small pockets of bone developed within peripheral regions of the PEGMA templates, while bone formation (although still somewhat peripheral) was more diffuse within the RGD-γ alginate and GelMA templates (Figure 2, a, e, i) . µCT analysis confirmed that each hydrogel supported the development 
Bioprinting of Mechanically Reinforced Cartilage Rudiments for Endochondral Bone Formation
After determining the optimum bioink (RGD-γ alginate) to engineer endochondral bone in vivo, we next sought to engineer a mechanically reinforced soft tissue templates suitable for load bearing applications by combining 3D printed PCL scaffolds (fibre diameter 437 ± 64 µm, porosity 67%) with an MSC laden bioink (Figure 3a) . Reinforcement with PCL led to a dramatic increase in the compressive modulus (3.867± 0.2187 kPa vs. 1402 ± 157.8 kPa; Figure 3b ), approaching that found for trabecular bone which can range from 1 MPa upwards depending on location [19] . To determine if incorporating a slowly degrading PCL phase into the MSC laden bioink influenced endochondral bone formation in vivo, these composite constructs were chondrogenically primed in vitro and then implanted subcutaneously in nude mice. In addition, we explored whether altering the construct architecture through incorporation of micro-channels into the composite bioink/PCL grafts would accelerate vascularisation and bone formation following implantation in vivo (bioink/PCL + Channels) [12] . All constructs (bioink, bioink/PCL & bioink/PCL + Channels) were chondrogenically ). µCT analysis confirmed significantly higher levels of mineralisation within the composite groups compared to the bioink control (Figure 4o ). The bone forming capacity of these printed constructs was also scalable, as geometrically larger templates were also found to vascularise and mineralise at similar levels to smaller engineered tissues ( Figure S4 ).
Bioprinting of Developmentally Inspired Cartilage Rudiments for Whole Bone Organ Engineering
We next explored the possibility of bioprinting a hypertrophic cartilage rudiment that could act as a template for the formation of a whole bone organ in vivo. A model of a human vertebrae was scanned using a PICZA 3D laser scanner and converted to stereolithographic (STL) format. Next the STL file was converted to g-code to control the deposition of PCL and MSC laden bioink filaments.
For this phase of the study, rather than infusing the MSC laden bioink into a pre-printed PCL network, the constructs were 3D bioprinted by co-depositing bioink filaments alongside PCL filaments in a layer by layer fashion using multiple-tool biofabrication to build a composite vertebrae structure . Near comparable levels of mineralisation were found when the bioink was switched from RGD-γ alginate to GelMA, demonstrating that mineralisation was not due to calcification of the RGD-γ alginate material itself ( Figure S5 c, d, e) . In addition, no mineralisation or bone were found in empty PCL controls where the constructs were filled with fibrous tissue (Figure S5 b, d ).
Discussion
In this study we demonstrate the feasibility of engineering an entire bone organ using a novel 3D bioprinting strategy. Using multiple-tool biofabrication, we were able to engineer an organ precursor in vitro which subsequently provided a template for the formation of its more complex adult counterpart in vivo. Having identified a suitable bioink to tissue engineer a cartilaginous rudiment, we then demonstrated that is was possible to mechanically reinforce this template using a network of printed PCL microfibers, resulting in composite constructs with a compressive modulus approaching that of cancellous bone. Finally, we leveraged the capacity of multiple-tool biofabrication to engineer a reinforced soft tissue template mimicking the geometry of a whole vertebrae. After chondrogenic priming, this construct was found to support the development of a functional bone organ in vivo.
The RGD-γ alginate bioink was found to support more robust chondrogenesis of MSCs in vitro and enhanced levels of endochondral bone formation in vivo compared to both the PEGMA and GelMA based bioinks. It is well established that alginate hydrogels can support robust chondrogenesis [20, 21] , with the incorporation of RGD peptides having previously been shown to lead to enhanced osteogenesis when this biomaterial is used for bone tissue engineering applications [15, 17] . Furthermore, we chose to use a gamma-irradiated alginate as the relatively slow degradation rate of this hydrogel in its non-modified form has previously been shown to impede endochondral bone regeneration [22] .
The alginate bioink was physically cross-linked using CaCl2 whereas the PEGMA and GelMA bioinks were both chemically cross linked using UV light. This could also contribute to the higher levels of endochondral bone formed in the alginate bioink as chemical cross links typically degrade slower. Furthermore, since both PEGMA and GelMA supported lower levels of chondrogenic differentiation in vitro, a lower number of MSCs likely reached the terminal hypertrophic phenotype in vivo, potentially also contributing to the lower levels of endochondral bone generated within these hydrogels. The higher levels of collagen type X staining found in the alginate hydrogel after 6 weeks of in vivo implantation support this hypothesis (Figure 2 d, h, l) .
It was possible to reinforce the MSC laden bioink with a network of PCL micro-fibres, thereby providing a level of mechanical functionality compatible with implanting such organ rudiments into load bearing locations in vivo. It should be clarified that no attempt was made to chemically crosslink the hydrogel bioink to the PCL fibres. This may be a potential limitation at higher strains and future work will explore improving the integrity of the interface through covalent attachment of the hydrogel to the PCL filaments [23] . Importantly, the capacity of these constructs to support endochondral bone formation was not compromised at the expense of the added mechanical functionality associated with the integration of the PCL micro-fibres. The RGD-γ alginate bioink within the PCL composites appeared to degrade at an accelerated rate compared to the solid bioink controls, likely due to the increased surface to volume ratio of the reinforced bioink. This at least partially explains the greater levels of host cell invasion and vascularisation throughout the composite constructs, which in turn can further accelerate degradation as host derived cells are known to play a key role in remodelling and removal of biomaterials [24] . In agreement with previous studies, bone formation occurred within regions of the construct where the RGD-γ alginate bioink had broken down providing space for vascularization and new tissue formation [21, 25] . Increases in oxygen availability associated with enhanced vascularization will in turn accelerate hypertrophy of the implanted grafts [26] . In fact, the capacity of the cartilaginous constructs to generate endochondral bone was improved by the incorporation of PCL. Although there was a trend toward higher levels of vascularisation in the channelled constructs, no significant increase in mineralization was found with the incorporation of these micro-channels as has been previously reported [12] . This may be due to the fact that the addition of PCL alone increased the surface to volume ratio of the RGD-γ alginate bioink as described above, hence no further benefits accrued through the incorporation of micro-channels.
In this study, we used PCL to provide structural support to the construct and RGD-γ-Alginate as a bioink to enable the printing of MSCs and to provide an environment conductive to chondrogenesis. The degradation rate of the PCL (MW above 45,000 g/mol) in vivo is slow, typically 24-30 months before the polymer breaks down into lower molecular weight fragments [27, 28] First the polymer surface is slowly degraded by hydrolytic cleavage at the surface resulting in thinning of the fibres followed by a more rapid phase of bulk degradation when water penetrates the entire polymer matrix. This slow degradation would be beneficial in high load bearing bone defects where long term support is required before the tissue can fully repair. The alginate hydrogel (MW 58,000 g/mol) will degrade more rapidly than the PCL polymer. Alginate hydrogels dissolve at neutral pH upon losing divalent cross linking cations to surrounding body fluids. Here we used a low molecular weight alginate hydrogel produced by irradiating (5mrad) the polymer as it has been shown that lower molecular weight gels are cleared more rapidly in vivo [16] . It has recently been shown in a rat femoral defect model that 60-70% of the polymer degrades away from the site of bone formation after 12 weeks of implantation [29] . Higher levels of irradiation (8mrad) can be utilised to produce alginate hydrogels that will lose 90% of their mass 2 weeks after implantation [16] .
Engineering of solid organs is the perhaps the ultimate aim of regenerative medicine, but remains elusive as current biofabrication strategies cannot recapitulate such intricate 3D structures [30] . The approach developed here facilitates the positioning of multiple materials and cells within 3D structures, enabling the engineering of pre-cursors to more complex organs. The approach could also be adapted to other biofabrication methods such as inkjet printing and electrospinning where cellular and extra cellular material can be arranged in complex patterns [31] . Future work will look at recapitulating biomolecule gradients that occur during skeletal developmental processes using bioprinted patterns of plasmid DNA encoding for vascular, chondrogenic and osteogenic factors such as VEGF, PDGF, TGF-β3 and BMP-2 [32] [33] [34] [35] . We will also explore the spatial and temporal control of these and other factors [3, 36] to help engineer the micro-environment of developing bones. Another major challenge in tissue engineering is integrating larger solid tissues with the surrounding host vasculature post implantation to maintain cell viability [37] . Here the vertebrae structures were well vascularised post-implantation, indicating that the engineered cartilage rudiments are capable of recruiting host vessels in vivo to support both implanted and recruited cells within the implant.
Conclusion
In conclusion, this study presents a novel biofabrication strategy for engineering whole bone organs by bioprinting developmentally inspired templates with the capacity to undergo endochondral ossification over time following implantation. By printing a customized MSC laden bioink alongside a network of reinforcing PCL microfibers, it was possible to engineer templates where biological and mechanical functionality are decoupled. The additional mechanical functionality provided by the codeposition of a PCL network during the printing process did not compromise the capacity of the implant to support endochondral bone formation, but should enable such 'developmentally immature' constructs to be implanted into challenging load-bearing environments. Finally, it was possible to engineer a vertebral body incorporating a functional vasculature, trabecular-like bone and a supporting marrow cavity using the approach. Taken together, these results demonstrate the promise of the proposed 3D bioprinting strategy for the engineering of whole bones for orthopaedic and craniofacial medicine. This concept of bioprinting developmental precursors could also be used to engineer other complex solid organs.
Experimental Section
Isolation and expansion of MSCs:
Bone marrow derived MSCs were isolated from the femoral shaft of 4 month old pigs and expanded as previously described [38] . Tri-potentiality was confirmed prior to use. Following colony formation, MSCs were trypsinized, counted, seeded at density of 5000 cells cm 2 in 500 cm 2 triple flasks (Thermo Fisher Scientific), supplemented with hgDMEM, 10% v/v FBS, 100 U ml -1 penicillin/100 μg ml -1 streptomycin, 2.5 μg ml -1 amphotericin B and 5 ng ml -1 human fibroblastic growth factor-2 (FGF-2;
Prospec-Tany TechnoGene Ltd., Israel) and expanded to passage 2. Separate donors were isolated for study 1, 2 & 3.
RGD-γ Alginate and GelMA Synthesis:
Low molecular weight sodium alginate (γ alginate, 58,000 g/mol) was prepared by irradiating sodium alginate (MVG, 259,000 g/mol, Pronova Biopolymers, Oslo, Norway) at a gamma dose of 5 Mrad, as previously described [16] . RGD-modified alginates were prepared by coupling the GGGGRGDSP to the alginate using standard carbodiimide chemistry. Briefly, 10 g alginate was dissolved at 1 w/v % in MES Buffer (0.1 M MES, 0.3 M NaCl and pH 6.5). 274 mg sulfo-NHS (Pierce, Rockford, IL), 484 mg EDC (Sigma), and 100 mg GGGGRGDSP peptide (AIBioTech, Richmond, VA) were then added into alginate solution. The reaction was stopped and the solution was purified and lyophilized as previously described [39] . GelMA was synthesized by reaction of porcine type A gelatin (Sigma Aldrich) with methacrylic anhydride (Sigma Aldrich) at 50 °C for four hours, as previously described [40] . Methacrylic anhydride was added to a 10% solution of gelatin in PBS under constant stirring. To achieve a high degree of functionalization, 0.6 g of methacrylic anhydride was added per gram of gelatin. The functionalized polymer was dialyzed against distilled water for 7 days at 40 °C to remove methacrylic acid and anhydride, freeze-dried and stored at -20 °C until use. NMR was used to confirm functionalisation of the alginate and GelMA hydrogels. PEGMA a polyethylene glycol methacrylamide based hydrogel was purchased from Regen Hu, Switzerland, sold as BioINK™.
Encapsulation of MSCs within alginate, RGD-γ alginate, PEGMA and GelMA Hydrogels:
To cast cylindrical hydrogels (5mm diameter X 3 mm height) RGD-γ alginate (2.45%), PEGMA (concentration undisclosed) and GelMA (10%, Irgacure 2959 0.05%) hydrogels were pipetted into custom developed agarose moulds at a cell density of 20 X 10 6 MSCs ml -1 . For fabrication of alginate hydrogels a 4% agarose/50mM CaCl2 mold was cast, and gelation was allowed to occur for 30 min at 37°. Bioink and GelMA constructs were cross-linked by applying UV light (Uvitec, Cambridge UK) for 30 mins (365nM, 180 mW/cm 2 ). All hydrogels concentrations were chosen for their optimum extrusion characteristics.
3D Bioprinting System:
PCL/bioink scaffolds were fabricated using the 3D Discovery multi-head bioprinting system purchased from Regen Hu, Switzerland. The 3D Discovery was set up to allow for co-printing of two pneumatic driven syringes containing bioinks alongside one fused deposition modeller allowing for deposition of melted polycaprolactone (PCL) (Sigma, Mn 45,000). First the RGD-γ alginate bioink was dissolved at 3.5 wt% and mixed thoroughly with 60mM CaCL2 [41] . A luer lock system was used to mix the alginate and calcium solutions in a 7:3 ratio. To ensure homogeneity the suspension was mixed between syringes 25 times. The solution (2.45 wt% RGD-γ alginate final) was next combined with BMSCs at the end of P2 (20 Million Cells/ml). Next the pre-cross linked MSC laden alginate solution was loaded into the pressure driven piston system and co-printed alongside PCL melted at 60° and 3D Bioprinted ( Figure 5A ). A pressure of 0.2 MPa and a 25 Gauge needle were used to deposit the bioink/MSC strands. Following this the constructs were immersed in a 50mM CaCl2 solution for 15 mins to fully cross link the alginate bioink. The 3D Discovery was placed in a laminar flow hood to ensure sterility throughout the biofabrication process. For the final study the vertebrae of a human skeleton model was scanned using a PICZA 3D Laser Scanner model LPX-250. 3D
computer-aided design software was used to render the scans. Next the scans were converted to g-code generated using BioCAD™ software (Regen HU, Switzerland) and vertebrae constructs were co-printed as previously described.
Due to difficulties in co-depositing the MSC laden bioink alongside PCL structure in smaller diameter constructs (< 6mm) the constructs used in study 2 were not co-printed. For fabrication of these smaller constructs first a PCL scaffold was deposited with a fibre spacing of 1 mm and placed in a 4%
agarose/50mM CaCl2 cylindrical mould. Next the RGD-γ Alginate constructs were fabricated by pipetting passage 2 MSC-laden (20 x 10 6 cells/mL) RGD-γ alginate solution (2.45 wt. %) into the mould around the PCL scaffold and allowing gelation to occur for 15mins (bioink/PCL) (Figure 3a) .
To form channels a 0.5mm biopsy punch was used to create six channels through the construct (bioink/PCL + channels) (Figure 3a ). Channels were introduced at the end of the 4 week in vitro culture period prior to implantation.
In vitro culture conditions:
Chondrogenic and hypertrophic culture conditions were applied as previously described [38] . For study one the in vitro priming protocol was defined as 4 weeks in chondrogenic conditions, for study 2 & 3 the in vitro priming protocol was defined as 3 weeks in chondrogenic conditions followed by one week in hypertrophic conditions. This was to accelerate transition of the cartilage matrix into bone in vivo [10, 42] .
In vivo subcutaneous implantation:
MSC-seeded RGD-γ alginate, PEGMA and GelMA hydrogels (n=9) were implanted subcutaneously into the back of nude mice (Balb/c; Harlan, UK) as previously described [43] . For the second study bioink, bioink/PCL and bioink/PCL channels (n=9) were implanted with 3 samples inserted per pocket. For larger constructs (10mmØ X 6mm height constructs from study 2 (n=3) and the vertebrae from study 3 (n=9)) only two constructs were implanted per animal due to the larger size. For study 1 the constructs were harvested after 6 weeks, for the second study the constructs were harvested after 4&12 weeks and for the third study the vertebrae constructs were harvested after 12 weeks. Mice were killed by CO2 inhalation and the animal protocol was reviewed and approved by the ethics committee of Trinity College Dublin and the Irish Medicines Board (IMB).
Biochemical analysis:
Sulphated proteoglycan (sGAG) and DNA content were quantified biochemically using the dimethyl methylene blue dye-binding (DMMB) assay and Hoechst Bisbenzimide 33258 dye assay as previously described [26] . To exclude any background absorbance from the individual biopolymers the PH of the DMMB was adjusted to 1.35 and day 0 sGAG values were subtracted from the week 4
values. Total collagen content was determined by measuring the hydroxyproline content using the dimethylaminobenzaldehyde and chloramine T assay and a hydroxyproline to collagen ratio of 1:7.69.
Histological and Immunohistochemical analysis:
Constructs were processed for histological analysis as previously described [21] . The sections were stained with haematoxylin and eosin (H&E) and goldner's trichrome to assess bone formation and aldehyde fuschin/alcian blue to assess sGAG content. Collagen types I, II and X were evaluated using a standard immunohistochemical technique as previously described [12] . Histomorphometric quantification was carried out using Adobe Photoshop® magic wand tool to isolate areas of bone formation on H&E stained sections and then quantified using image J as previously described [44] .
The presence of vascular structures were quantified by counting distinct areas of red blood cell activity as a blood vessel. The number of blood vessels across a whole cross section were then counted.
Live/dead confocal microscopy:
Cell viability was assessed after 24 h using a LIVE/DEAD™ viability/cytotoxicity assay kit as previously described [45] . Live dead quantification was carried out using image J.
Microcomputed tomography:
Microcomputed tomography (µCT) scans were performed as previously described [21] . A Gaussian filter (sigma = 0.8, support = 1) was used to suppress noise and a global threshold of 150 corresponding to a density of 254.59 mg hydroxyapatite/cm 3 was applied. A voxel resolution of 12µm was used throughout. The variance of mineralization with depth through the constructs was analysed qualitatively by examining sections at a depth of 25% and 50% from the top of the construct (quarter & mid-section).
Mechanical Characterisation:
Samples were tested in unconfined compression as previously described [46] . Stress tests were performed with a ramp displacement of 1 mm/s until 10% strain. The compressive modulus was taken as the slope of the stress strain curve between 0-10% strain.
Statistical analysis:
Statistical analysis was performed as previously described [47] . Briefly tukey's test for multiple comparisons was used to compare conditions. Significance was accepted at a level of p ≤ 0.05, with all graphs representing mean ± standard. 
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